ArticleFrontiers in pharmacology2026
Exploring the association between pharmacy curricular tracks and students' attitudes toward generic medicines: insights from a comparative study in Egypt.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Use of generic medicines enhances drug affordability and accessibility. The aim if this study was to assess the association between pharmacy educational programs and final-year pharmacy students' perceptions and confidence in generic medicines. Methodology: A cross-sectional survey was conducted in July 2025 among 248 fifth-year pharmacy students enrolled in two educational programs at Badr University in Cairo (BUC): the Pharm D Clinical Pharmacy program and the Pharm D program. The survey assessed knowledge of generic equivalency and beliefs regarding the quality, safety, and effectiveness of generic medicines compared to those of brand medications. Descriptive statistics, Chi-square test, and confidence intervals were used for data analysis, with a significance level set at p < 0.050. Results: Awareness of generic drug therapeutic equivalence was significantly higher in the Pharm D program than in the Pharm D clinical program (93.4% vs. 70.3%; p = 0.010; 95% CI: 0.02-0.10; Cramér's V = 0.35). However, a notable proportion in both groups reported limited education regarding detailed bioequivalence issues. A substantial proportion of students in both programs reported the need for enhanced education about safety and efficacy of generics, especially in the clinical program (89.3% vs. 68.9%, p = 0.010; 95% CI: 0.02-0.10; Cramér's V = 0.33). Conclusion: We identified significant differences in knowledge and attitudes regarding generic drugs between the two pharmacy programs. These differences are likely associated with variations in curriculum structure and content. Although general knowledge appears adequate, the Pharm D Clinical Pharmacy program may benefit from more targeted educational tracks about bioequivalence, quality assurance, and pharmacoeconomics that may better prepare future pharmacists to confidently recommend generic medications. Further multicenter studies are recommended to validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.